Ken Liu

3.5k total citations · 2 hit papers
122 papers, 2.2k citations indexed

About

Ken Liu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Ken Liu has authored 122 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 52 papers in Surgery and 45 papers in Epidemiology. Recurrent topics in Ken Liu's work include Liver Disease and Transplantation (38 papers), Organ Transplantation Techniques and Outcomes (28 papers) and Liver Disease Diagnosis and Treatment (28 papers). Ken Liu is often cited by papers focused on Liver Disease and Transplantation (38 papers), Organ Transplantation Techniques and Outcomes (28 papers) and Liver Disease Diagnosis and Treatment (28 papers). Ken Liu collaborates with scholars based in Australia, Hong Kong and United States. Ken Liu's co-authors include Geoffrey W. McCaughan, Arthur J. Kaffes, Simone I. Strasser, Weiqi Xu, Jun Yu, Xiang Zhang, Terry Cheuk‐Fung Yip, David Prince, Grace Lai–Hung Wong and Zhi‐Xiu Lin and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Ken Liu

112 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019

2023 93 citations Ken Liu et al. profile →
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions

2024 55 citations Lung‐Yi Mak, Ken Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Liu Australia	26	745	720	546	400	315	122	2.2k
Xavier Verhelst Belgium	25	692 0.9×	898 1.2×	425 0.8×	439 1.1×	138 0.4×	104	1.8k
Taku Naiki Japan	29	631 0.8×	718 1.0×	599 1.1×	776 1.9×	301 1.0×	183	2.6k
Roberto Gedaly United States	24	733 1.0×	596 0.8×	651 1.2×	592 1.5×	556 1.8×	106	2.3k
Howard Monsour United States	19	1.1k 1.5×	868 1.2×	618 1.1×	458 1.1×	307 1.0×	41	2.3k
Gopal Krishna Dhali India	18	594 0.8×	1.0k 1.4×	480 0.9×	372 0.9×	152 0.5×	82	2.0k
David W. Victor United States	20	696 0.9×	752 1.0×	524 1.0×	437 1.1×	366 1.2×	70	2.0k
Joseph A. Odin United States	29	1.1k 1.4×	1.0k 1.4×	389 0.7×	522 1.3×	255 0.8×	69	2.4k
Umberto Vespasiani‐Gentilucci Italy	25	663 0.9×	1.2k 1.7×	430 0.8×	480 1.2×	339 1.1×	111	2.3k
Manuel Rodríguez‐Perálvarez Spain	27	1.5k 2.0×	982 1.4×	1.0k 1.9×	376 0.9×	429 1.4×	87	2.8k
In Hee Kim South Korea	24	459 0.6×	615 0.9×	248 0.5×	595 1.5×	194 0.6×	95	1.8k

Countries citing papers authored by Ken Liu

Since Specialization

Citations

This map shows the geographic impact of Ken Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Liu more than expected).

Fields of papers citing papers by Ken Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Liu. The network helps show where Ken Liu may publish in the future.

Co-authorship network of co-authors of Ken Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Liu. A scholar is included among the top collaborators of Ken Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Liu. Ken Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mak, Lung‐Yi, Jimmy Che‐To Lai, Ken Liu, et al.. (2025). Chronic Hepatitis B Infection: Patient Guidance. Journal of Gastroenterology and Hepatology. 41(1). 61–77.

Parker, Richard, Guruprasad P. Aithal, Michael Allison, et al.. (2025). Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. The American Journal of Gastroenterology.

Liu, Ken, et al.. (2025). Carbapenemase‐Producing Enterobacterales: An Increasing Threat to Australian Liver Transplant Recipients. Transplant Infectious Disease. 27(2). e14432–e14432.

Prince, David, David Baker, Ken Liu, et al.. (2024). Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance. Journal of Gastroenterology and Hepatology. 40(1). 250–257. 1 indexed citations

Marsh‐Wakefield, Felix, Angela L. Ferguson, Thomas M. Ashhurst, et al.. (2024). Spatial mapping of the HCC landscape identifies unique intratumoral perivascular-immune neighborhoods. Hepatology Communications. 8(11). 2 indexed citations

Chen, Shujie, et al.. (2024). Hypomagnesaemia, an independent risk factor for the development of post‐transplant diabetes mellitus in liver and renal transplant recipients? A systematic review. Journal of Human Nutrition and Dietetics. 37(6). 1407–1419. 1 indexed citations

Nicoll, Amanda, Jacob George, David Prince, et al.. (2024). Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia. Alimentary Pharmacology & Therapeutics. 59(8). 953–961. 3 indexed citations

Dennis, Claude V., Jinbiao Chen, Chuanmin Wang, et al.. (2024). Long-term ex situ normothermic machine perfusion allows regeneration of human livers with severe bile duct injury. American Journal of Transplantation. 25(1). 60–71. 5 indexed citations

McCaughan, Geoffrey W., et al.. (2024). Long-term machine perfusion of human split livers: a new model for regenerative and translational research. Nature Communications. 15(1). 9809–9809.

10.

Marinelli, Tina, et al.. (2024). Low rate of surgical site infections after liver transplantation: A 5‐year retrospective cohort study. Transplant Infectious Disease. 26(4). e14280–e14280. 2 indexed citations

11.

Li, Peng, et al.. (2024). CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis. Technology in Cancer Research & Treatment. 23. 2233979327–2233979327. 2 indexed citations

12.

Dennis, Claude V., Marti Cabanes‐Creus, Chuanmin Wang, et al.. (2023). Liver splitting during normothermic machine perfusion: a novel method to combine the advantages of both in-situ and ex-vivo techniques. HPB. 25(5). 543–555. 18 indexed citations

13.

Liu, Ken, et al.. (2023). Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers. Artificial Organs. 48(5). 472–483. 5 indexed citations

14.

Strasser, Simone I., et al.. (2023). Acute liver failure secondary to green tea extract. Pathology. 56(4). 597–599. 2 indexed citations

15.

Liu, Ken, et al.. (2022). Outcomes of patients with hepaticojejunostomy anastomotic strictures undergoing endoscopic and percutaneous treatment. SHILAP Revista de lepidopterología. 11(1). E24–E31. 3 indexed citations

16.

Liu, Ken, et al.. (2022). Successful liver transplantation for hepatitis B‐related acute liver failure in a patient with active COVID‐19. Transplant Infectious Disease. 24(4). e13889–e13889. 4 indexed citations

17.

Laube, Robyn, et al.. (2021). Palliative medicine referrals for hepatocellular carcinoma: a national survey of gastroenterologists. BMJ Supportive & Palliative Care. 14(e1). e936–e944. 4 indexed citations

18.

Liu, Ken, Gontran Verset, Eric Trépo, & Devanshi Seth. (2020). Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction. Hepatoma Research. 2020. 7 indexed citations

19.

Liu, Ken, Jinbiao Chen, & Geoffrey W. McCaughan. (2020). Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases. Hepatoma Research. 2020. 6 indexed citations

20.

Liu, Ken, Jonggi Choi, An K. Le, et al.. (2019). Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis. Alimentary Pharmacology & Therapeutics. 50(9). 1037–1048. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact